F. Caux, Diagnosis and clinical features of epidermolysis bullosa acquisita, Dermatol Clin, vol.29, pp.485-91, 2011.

R. Gupta, D. T. Woodley, and M. Chen, Epidermolysis bullosa acquisita, Clin Dermatol, vol.30, pp.60-69, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01545787

P. Bernard and C. Bédane, Dermatoses bulleuses auto-immunes sous-épidermiques, EMC-Dermatol, vol.6, pp.1-17, 2011.

J. C. Lapiere, D. T. Woodley, M. G. Parente, T. Iwasaki, K. C. Wynn et al., Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa, J Clin Invest, vol.92, pp.1831-1840, 1993.

L. Asfour, H. Chong, J. Mee, R. Groves, and M. Singh, Epidermolysis bullosa acquisita (Brunsting-Perry pemphigoid variant) localized to the face and diagnosed with antigen identification using skin deficient in type VII collagen, Am J Dermatopathol, vol.39, pp.90-96, 2017.

J. H. Kim, Y. H. Kim, and S. Kim, Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases, Acta Derm Venereol, vol.91, pp.307-319, 2011.

L. Roux-villet, C. Prost-squarcioni, C. Heller, M. Hamel-teillac, D. Joly et al., Epidermolysis bullosa acquisita: a clinical, histological and immunological study of 39 cases, Ann Dermatol Venereol, vol.129, pp.71-73, 2002.

W. R. Gammon, R. A. Briggaman, D. T. Woodley, P. W. Heald, and C. E. Wheeler, Epidermolysis bullosa acquisita : a pemphigoid-like disease, J Am Acad Dermatol, vol.11, pp.820-852, 1984.

P. Joly, F. Ruto, E. Thomine, A. Delpech, X. Balguerie et al., Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa?, J Am Acad Dermatol, vol.28, pp.89-92, 1993.

M. A. Saleh, K. Ishii, Y. Kim, A. Murakami, N. Ishii et al., Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients, J Dermatol Sci, vol.62, pp.169-75, 2011.

M. Mayuzumi, M. Akiyama, W. Nishie, S. Ukae, M. Abe et al., Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature, Br J Dermatol, vol.155, pp.1048-52, 2006.

M. Elqatni, J. Fatihi, Y. Sekkach, S. Hammi, T. Ameziane et al., Des lésions bulleuses, Rev Med Interne, vol.31, pp.863-867, 2010.

L. A. Brunsting and H. O. Perry, Benign pemphigoid; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck, AMA Arch Derm, vol.75, pp.489-501, 1957.

G. S. Choi, E. S. Lee, S. C. Kim, and S. Lee, Epidermolysis bullosa acquisita localized to the face, J Dermatol, vol.25, pp.19-22, 1998.

G. Kurzhals, W. Stolz, W. Maciejewski, S. Karpati, M. Meurer et al., Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid, Arch Dermatol, vol.131, pp.580-585, 1995.

H. Minato, N. Ishii, S. Fukuda, T. Wakasa, K. Wakasa et al., Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa, J Dermatol, vol.38, pp.887-92, 2011.

Y. Murata, M. Tani, and K. Kumano, Localized chronic pemphigoid of Brunsting-Perry. Ultrastructural localization of IgG and complement components, Arch Dermatol, vol.119, pp.921-925, 1983.

H. Jedlickova, A. Niedermeier, S. Zga?arová, and M. Hertl, Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332, Dermatol Basel Switz, vol.222, pp.193-198, 2011.

T. Demitsu, M. Kakurai, K. Yoneda, E. Iida, M. Takada et al., Localized pemphigoid (BrunstingPerry type) with IgG antibody to BP180 NC16a domain resembling lupus erythematosus successfully treated with topical tacrolimus therapy, J Eur Acad Dermatol Venereol, vol.23, pp.79-80, 2009.

J. Daito, N. Katoh, J. Asai, E. Ueda, H. Takenaka et al., Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180, Br J Dermatol, vol.159, pp.984-990, 2008.

S. Takeichi, Y. Kubo, S. Arase, T. Hashimoto, and S. Ansai, Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure, Eur J Dermatol, vol.19, pp.500-503, 2009.

P. García-martín, J. Fraga, T. Hashimoto, and A. García-diez, Brunsting-Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1, Br J Dermatol, vol.170, pp.743-748, 2014.

G. Kurzhals, W. Stolz, M. Meurer, J. Kunze, O. Braun-falco et al., Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid, Arch Dermatol, vol.127, pp.391-396, 1991.

C. W. Lee and K. M. Jun, Epidermolysis bullosa acquisita presenting with localized facial blisters, Clin Exp Dermatol, vol.17, pp.363-368, 1992.

V. Leenutaphong, R. Von-kries, and G. Plewig, Localized cicatricial pemphigoid (Brunsting-Perry): electron microscopic study, J Am Acad Dermatol, vol.21, pp.1089-93, 1989.

F. Caux, Diagnosis and clinical features of epidermolysis bullosa acquisita, Dermatol Clin, vol.29, pp.485-91, 2011.

R. Gupta, D. T. Woodley, and M. Chen, Epidermolysis bullosa acquisita, Clin Dermatol, vol.30, pp.60-69, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01545787

J. H. Kim, Y. H. Kim, and S. Kim, Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases, Acta Derm Venereol, vol.91, pp.307-319, 2011.

L. Asfour, H. Chong, J. Mee, R. Groves, and M. Singh, Epidermolysis bullosa acquisita (Brunsting-Perry pemphigoid variant) localized to the face and diagnosed with antigen identification using skin deficient in type VII collagen, Am J Dermatopathol, vol.39, pp.90-96, 2017.

P. Bernard and C. Bédane, Dermatoses bulleuses auto-immunes sous-épidermiques, EMC-Dermatol, vol.6, pp.1-17, 2011.

L. A. Brunsting and H. O. Perry, Benign pemphigoid; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck, AMA Arch Derm, vol.75, pp.489-501, 1957.

G. Kurzhals, W. Stolz, M. Meurer, J. Kunze, O. Braun-falco et al., Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid, Arch Dermatol, vol.127, pp.391-396, 1991.

W. R. Gammon, R. A. Briggaman, D. T. Woodley, P. W. Heald, and C. E. Wheeler, Epidermolysis bullosa acquisita : a pemphigoid-like disease, J Am Acad Dermatol, vol.11, pp.820-852, 1984.

P. Joly, F. Ruto, E. Thomine, A. Delpech, X. Balguerie et al., Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa?, J Am Acad Dermatol, vol.28, pp.89-92, 1993.

P. Bernard, L. Vaillant, B. Labeille, C. Bedane, B. Arbeille et al., Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group, Arch Dermatol, vol.131, pp.48-52, 1995.

J. Loget, J. Plée, C. Barbe, S. Duvert-lehembre, A. Couraud et al., Évaluation de l'incidence et de la répartition des différentes dermatoses bulleuses auto-immunes dans 3 régions françaises par le registre REGIBUL, Ann Dermatol Vénéréologie, vol.142, p.511, 2010.

G. Kurzhals, W. Stolz, W. Maciejewski, S. Karpati, M. Meurer et al., Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid. Report of a case proved by preembedding immunogold electron microscopy, Arch Dermatol, vol.131, pp.580-585, 1995.

M. Chen, A. Doostan, P. Bandyopadhyay, R. J. Wang, X. Hou et al., The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita, Am J Pathol, vol.170, pp.2009-2027, 2007.

M. Chen, E. A. O'toole, J. Sanghavi, M. N. Kelleher, D. Weir et al., The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen, J Invest Dermatol, vol.118, pp.1059-64, 2002.

J. Lohi, I. Leivo, T. Tani, T. Kiviluoto, E. Kivilaakso et al., Laminins, tenascin and type VII collagen in colorectal mucosa, Histochem J, vol.28, pp.431-471, 1996.

M. I. Stewart, D. T. Woodley, and R. A. Briggaman, Epidermolysis bullosa acquisita and associated symptomatic esophageal webs, Arch Dermatol, vol.127, pp.373-380, 1991.

L. Roux-villet, C. Prost-squarcioni, C. Heller, M. Hamel-teillac, D. Joly et al., Epidermolysis bullosa acquisita: a clinical, histological and immunological study of 39 cases, Ann Dermatol Venereol, vol.129, pp.71-72, 2002.

M. Furue, M. Iwata, H. I. Yoon, Y. Kubota, H. Ohto et al., Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer, J Am Acad Dermatol, vol.14, pp.873-881, 1986.

T. Schmidt, M. Hoch, L. Jad-s-s, F. Solimani, D. Zenzo et al., Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita-a multicenter analysis, Br J Dermatol, 2017.

K. Wozniak, T. Hashimoto, N. Ishii, H. Koga, M. Huczek et al., Fluorescence overlay antigen mapping using laser scanning confocal microscopy differentiates linear IgA bullous dermatosis from epidermolysis bullosa acquisita mediated by IgA, Br J Dermatol, vol.168, pp.634-642, 2013.

M. Sato-shibuya, T. Dainichi, G. Egawa, T. Honda, A. Otsuka et al., Case with BrunstingPerry-like localized subepidermal blister formations and immunoglobulin G antibodies against unidentified basement membrane zone antigen, J Dermatol, vol.43, pp.426-434, 2016.

N. Ishii, T. Hamada, T. Dainichi, T. Karashima, T. Nakama et al., Epidermolysis bullosa acquisita: what's new ?, J Dermatol, vol.37, pp.220-250, 2010.

A. Adachi, M. Komine, M. Suzuki, S. Murata, T. Hirano et al., Oral colchicine monotherapy for epidermolysis bullosa acquisita: mechanism of action and efficacy, J Dermatol, vol.43, pp.1389-91, 2016.

D. F. Mutasim, Management of autoimmune bullous diseases: pharmacology and therapeutics, J Am Acad Dermatol, vol.51, pp.859-877, 2004.

L. Intong and D. F. Murrell, Management of epidermolysis bullosa acquisita, Dermatol Clin, vol.29, pp.643-650, 2011.

L. L. Crow, J. P. Finkle, W. R. Gammon, and D. T. Woodley, Clearing of epidermolysis bullosa acquisita with cyclosporine, J Am Acad Dermatol, vol.19, pp.937-979, 1988.

J. Tu and K. Kumarasinghe, Epidermolysis bullosa acquisita with mode retely severe dysphagia due to esophageal strictures, Indian J Dermatol, vol.56, pp.224-227, 2011.

S. Naveed and . Mycophenolate, MMF) in the treatement of epidermolysis bullosa acquisita (EBA) long-term follow-up, JAAD Case Rep, vol.1, pp.321-323, 2015.

G. Kirtschig, D. Murrell, F. Wojnarowska, and N. Khumalo, Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database of Systematic Reviews, 2003.

J. H. Kim, S. E. Lee, and S. Kim, Successful treatment of epidermolysis bullosa acquisita with rituximab therapy, J Dermatol, vol.39, pp.477-486, 2012.

A. Cavailhes, B. Balme, D. Gilbert, and F. Skowron, Successful use of combined corticosteroids and rituximab in the treatment of recalcitrant epidermolysis bullosa acquisita, Ann Dermatol Venereol, vol.136, pp.795-804, 2009.

B. Baroudjian, L. Roux-villet, C. Bréchignac, S. Alexandre, M. Caux et al., Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita, Eur J Dermatol, vol.22, pp.795-802, 2012.

A. Oktem, B. N. Akay, A. Boyvat, N. Kundakci, C. Erdem et al., Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy, J Dermatol Treat, vol.28, pp.50-54, 2017.

M. Kolesnik, E. Becker, D. Reinhold, A. Ambach, M. U. Heim et al., Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication, J Eur Acad Dermatol Venereol, vol.28, pp.771-80, 2014.

C. Prost, B. Labeille, V. Chaussade, J. Guillaume, N. Martin et al., Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a Prospective study of IgG and C3 bound In vivo in 32 patients, J Invest Dermatol, vol.89, pp.567-73, 1987.

M. Tani, M. Tani, A. Komura, and Y. Murata, Bullous pemphigoid of childhood: Report of a case and immunoelectron microscopic studies, J Am Acad Dermatol, vol.19, pp.366-373, 1988.

L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille et al., Evaluation of clinical criteria for diagnosis of bullous pemphigoid, French Bullous Study Group. Arch Dermatol, vol.134, pp.1075-80, 1998.

P. Bernard and C. Bédane, Dermatoses bulleuses auto-immunes sous-épidermiques, EMC-Dermatol, vol.6, pp.1-17, 2011.

T. Nagano, M. Tani, A. Adachi, T. Takanaga, S. Sakamoto et al., Childhood bullous pemphigoid: Immunohistochemical, immunoelectron microscopic, and Western blot analysis, J Am Acad Dermatol, vol.30, pp.884-892, 1994.

J. Fine, G. R. Neises, and S. I. Katz, Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid, J Invest Dermatol, vol.82, pp.39-43, 1984.

P. Bernard, C. Prost, V. Lecerf, L. Intrator, P. Combemale et al., Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis, J Invest Dermatol, vol.94, pp.630-635, 1990.

M. F. Jonkman, J. Schuur, F. Dijk, K. Heeres, M. C. De-jong et al., Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3, Arch Dermatol. févr, vol.136, pp.227-258, 2000.

S. Jain, V. Basavaraj, and M. G. Vimala, Utility of direct immunofluorescence studies in subclassification of autoimmune sub-epidermal bullous diseases: a 2-year study in a tertiary care hospital, Turk Patoloji Derg, vol.32, pp.91-99, 2016.

T. De-risi-pugliese, C. Aubart, F. Haroche, J. Moguelet, P. Grootenboer-mignot et al., Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases, Semin Arthritis Rheum, 2017.

R. M. Vodegel, M. F. Jonkman, H. H. Pas, and M. De-jong, U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases, Br J Dermatol, vol.151, pp.112-120, 2004.

J. Alonso-llamazares, L. E. Gibson, and R. S. Rogers, Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience, Int J Dermatol, vol.46, pp.910-919, 2007.

G. S. Choi, E. S. Lee, S. C. Kim, and S. Lee, Epidermolysis bullosa acquisita localized to the face, J Dermatol, vol.25, pp.19-22, 1998.

H. Minato, N. Ishii, S. Fukuda, T. Wakasa, K. Wakasa et al., Heterogeneity of BrunstingPerry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa, J Dermatol, vol.38, pp.887-92, 2011.

Y. Murata, M. Tani, and K. Kumano, Localized chronic pemphigoid of Brunsting-Perry. Ultrastructural localization of IgG and complement components, Arch Dermatol, vol.119, pp.921-925, 1983.

H. Tanaka, A. Ishida-yamamoto, T. Hashimoto, K. Hiramoto, T. Harada et al., A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen, Lab Investig J Tech Methods Pathol, vol.77, pp.623-655, 1997.

C. W. Lee and K. M. Jun, Epidermolysis bullosa acquisita presenting with localized facial blisters, Clin Exp Dermatol, vol.17, pp.363-368, 1992.

P. Bernard, C. Prost, V. Lecerf, L. Intrator, P. Combemale et al., Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis, J Invest Dermatol, vol.94, pp.630-635, 1990.

D. Villone, A. Fritsch, M. Koch, L. Bruckner-tuderman, U. Hansen et al., Supramolecular nteractions in the Dermo-epidermal Junction Zone: anchoring fibril-collagen VII tightly binds to bandes collagen fibrils, J Biol Chem, vol.283, pp.24506-24519, 2008.

, Caractéristiques des différentes dermatoses bulleuses sous-épidermiques en histologique, immunofluorescence directe (IFD) et immunomicroscopie électronique (IME). (PNE : polynucléaire éosinophile, PNN : polynucléaire neutrophile, vol.3